Today, the abortion pill will kill considerably more children than surgical abortion in the United States. Accessible online and through the mail, there are virtually no barriers to procuring the drug, which was created for the singular purpose of killing the child in the womb. And not surprisingly, the drug is incredibly dangerous to the women who ingest it. But we cannot allow Washington to discuss the maternal safety data and not the child fatality data that go along with it. We cannot end abortion without talking about its primary victim. A landmark study by the Ethics and Public Policy Center, the largest of its kind ever conducted, analyzed insurance claims from 865,727 mifepristone abortions between 2017 and 2023. What researchers found should concern every physician, regulator, and policymaker in America: More than 1 in 10 women who take the chemical abortion drug suffer a serious adverse event within 45 days. Sepsis. Hemorrhage. Life-threatening infection. The real-world serious adverse event rate is at least 22 times higher than what appears on the drug label — the same label the Food and Drug Administration and the drug’s manufacturer, Danco Laboratories, have used to market mifepristone as “safe and effective.”It is not.